OR WAIT null SECS
January 02, 2009
Editors' Picks of Pharmaceutical Science & Technology Innovations
The incoming administration has renewed hope for stem cells, but less adequate copycats may follow.
Will more resources and new leadership fix FDA, or is a major overhaul in order?
Instead of hampering progress, cost pressures might inspire Big Pharma to get creative.
December 29, 2008
Also, Crucell and DSM announce deals with GSK, Talecris, and CSL; Nobel Prize winner Luc Montagnier joins Viral Genetics; more...
December 18, 2008
Also, BASF opens lab in Mumbai; Evotek president and CEO to resign; more...
December 17, 2008
A surprising amount of the discovery and development life cycle is still based on manual and disconnected process steps.
December 11, 2008
Also, NicOx and DSM make manufacture and supply pact for naproxcinod drug substance; NovaRx appointed Norrie Russell president and COO; more...
December 04, 2008
Also, AstraZeneca announces changes to its supply chain operations; Christian Velmer appointed head of Wyeth Canada; More...
December 02, 2008
The past year saw major acquisitions attempted, completed, rejected, and stalled.